Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neutrophil response to aspirin and ticagrelor in healthy volunteers
ACTRN12624001100583Phase 4Not yet recruiting
- Sponsor
- Victoria University of Wellington
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin and ticagrelor, sponsored by Victoria University of Wellington. Primary endpoints: Neutrophil immunophenotyping, Phagocytosis capacity and 1 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
aspirinticagrelor
Beyond the preview
Go deeper on ACTRN12624001100583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001100583.